Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
922
datasets available to search
ShareScore release 0.9.0
Dataset results
922 results for “Chronic lymphocytic leukemia”
UC-961 (Cirmtuzumab) in Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT02222688. IPD Sharing: Not stated. Countries: 1. Publications: 1.
FCR and Bevacizumab in the Treatment of Relapsed Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT00448019. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Ublituximab in Combination With Ibrutinib Versus Ibrutinib Alone in Participants With Previously Treated High-Risk Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT02301156. IPD Sharing: NO. Countries: 2. Publications: 1.
A Study of Ibrutinib in Combination With Bendamustine and Rituximab in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01611090. IPD Sharing: Not stated. Countries: 21. Publications: 5.
Fludarabine (Fludara®) Plus Alemtuzumab (CAMPATH®, MabCampath®) vs Fludarabine Alone in B-Cell Chronic Lymphocytic Leukemia (B-CLL) Patients
ClinicalTrials.gov study NCT00086580. IPD Sharing: Not stated. Countries: 15. Publications: 1.
Fixed Duration Pirtobrutinib and Obinutuzumab in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT06333262. IPD Sharing: YES. Countries: 1. Publications: 0.
Lenalidomide and Ofatumumab in Treating Participants With Previously Treated Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT01002755. IPD Sharing: Not stated. Countries: 1. Publications: 1.
A Study on Rituximab (MabThera) in Participants With Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01178086. IPD Sharing: Not stated. Countries: 1. Publications: 1.
ACP-196 (Acalabrutinib), a Novel Bruton Tyrosine Kinase (BTK) Inhibitor, for Treatment of Chronic Lymphocytic Leukemia, Richter's Syndrome or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT02029443. IPD Sharing: YES. Countries: 3. Publications: 8.
A Multicenter Phase 2 Study of Ibrutinib in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL) With 17p Deletion
ClinicalTrials.gov study NCT01744691. IPD Sharing: NO. Countries: 9. Publications: 1.
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 1a)
ClinicalTrials.gov study NCT01010061. IPD Sharing: Not stated. Countries: 26. Publications: 4.
Study of Lenalidomide to Evaluate Safety and Efficacy in Patients With Relapsed or Refractory Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00963105. IPD Sharing: Not stated. Countries: 8. Publications: 2.
CLL11: A Study of Obinutuzumab (RO5072759 [GA101]) With Chlorambucil in Patients With Previously Untreated Chronic Lymphocytic Leukemia (Stage 2)
ClinicalTrials.gov study NCT02053610. IPD Sharing: Not stated. Countries: 26. Publications: 1.
Intermittent Duvelisib Dosing in Treating Patients With Chronic Lymphocytic Leukemia or Small Lymphocytic Lymphoma
ClinicalTrials.gov study NCT03961672. IPD Sharing: NO. Countries: 1. Publications: 0.
Safety and Tolerability Study of PCI-32765 Combined With Fludarabine/Cyclophosphamide/Rituximab (FCR) and Bendamustine/Rituximab (BR) in Chronic Lymphocytic Leukemia (CLL)
ClinicalTrials.gov study NCT01292135. IPD Sharing: Not stated. Countries: 1. Publications: 1.
5-Azacytidine (Azacytidine; Vidaza) in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00413478. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Safety of PCI-32765 in Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT01105247. IPD Sharing: Not stated. Countries: 1. Publications: 11.
Phase 2 Study of the Combination of Bruton's Tyrosine Kinase Inhibitor PCI-32765 and Rituximab in High-Risk Chronic Lymphocytic Leukemia and Small Lymphocytic Lymphoma Patients
ClinicalTrials.gov study NCT01520519. IPD Sharing: Not stated. Countries: 1. Publications: 1.
Flavopiridol in Treating Patients With Chronic Lymphocytic Leukemia or Prolymphocytic Leukemia
ClinicalTrials.gov study NCT00098371. IPD Sharing: Not stated. Countries: 1. Publications: 4.
Alemtuzumab and Rituximab in Treating Patients With High-Risk, Early-Stage Chronic Lymphocytic Leukemia
ClinicalTrials.gov study NCT00436904. IPD Sharing: Not stated. Countries: 1. Publications: 2.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.